Photo of Anne Hurlet-Jensen

Anne Hurlet-Jensen

  • ASSOCIATE PROFESSOR Pediatrics, Hematology/Oncology
Print ProfilePrint Profile

Certifications

  • Pediatric Hematology & Oncology

  • American Board of Pediatrics

Clinical Focus

  • Benign Hematology
  • Bleeding Disorders
  • Bone Marrow Failure
  • Hemophilia A & B
  • Hypercoagulability
  • Sickle Cell Disease/Sickle Cell Anemia
  • Thalassemia Major And Minor
  • Thrombocytopenia
  • Thrombosis

Education

  • MD, Liege University

  • Residency, Pediatrics
    Liege University

  • Residency, Hematology
    Necker Enfant Malade Hospital

  • Residency, Pediatrics
    Univ of Medicine & Dentistry of NJ

  • Fellowship, Hematology-Oncology
    New York University Medical Center

Biography

    Dr. Hurlet is board certified in Pediatric Hematology/Oncology by the American Board of Pediatrics.

    Dr. Hurlet's areas of expertise include: Neonatal Hemostasis, Thrombosis, Coagulopathy, Stroke prevention in patients with Sickle Cell disease.

Awards

  • 1972 -
    Maurice Meyer Prize

Publications

Berdon WE, Haller JO, Ruzal-Shapiro C, Hurlet A, Levin TL. Intrasplenic masses of 'preserved' functioning splenic tissue in sickle cell disease: correlation of imaging findings (CT, ultrasound, MRI, and nuclear scintigraphy). Pediatr Radiol 1996 Sep; 26(9): 646-9.

Sano M, Haggerty R, Kugler S, Martin B, Prohovnik I, Hurlet A, Piomelli S, De Vivo D. Neuropsychological consequences of the Sickle Cell Disease. Neuropsychiatry Neuropsychol Behav Neurol 1996; 9: 242-7.

Sheth S , Ruzal-Shapiro C , Hurlet A, Piomelli S , Berdon WE. Pulmonary embolism developing in patients with sickle cell disease on hypertransfusion and IV deferoxamine chelation therapy. Pediatr Radiol 1997 Dec; 27(12): 926-8.

Koumbourlis AC, Hurlet A, Bye MR. Lung function in infants with sickle cell disease. Pediatr Pulmonol 1997 Oct; 24(4): 277-81.

Adams RJ, Adams RJ, Mckie VC, Brambilla D, Carl E, Gallagher D, Nichols FT, Roach S, Abboud M, Berman B, Driscoll C, Files B, Hsu L, Hurlet A, Miller S, Olivieri N, Pegelow C, Scher C, Vichinsky E, Wang W, Woods G, Kutlar A, Wright E, Hagner S, Tighe F, Waclawiw MA. Stroke prevention trial in sickle cell anemia. Control Clin Trials 1998 Feb; 19(1): 110-29.

Adams RJ, Mckie V, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols FT, Bonds DR, Brambilla D, Woods G, Olivieri N, Driscoll C, Miller S, Wang W, Hurlet A, Scher C, Berman B, Carl E, Jones AM, Roach ES, Wright E, Zimmerman RA, Waclawiw M. Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography. N Engl J Med 1998 Jul; 339: 5-11.

Koumbourlis AC, Zar HJ, Hurlet A, Goldberg MR. Prevalence and reversibility of lower airway obstruction in children with sickle cell disease. J Pediatr 2001 Feb; 138(2): 188-92.

Miller ST, Wright E, Kutlar A, Mckie V, Wang W, Pegelow CH, Driscoll C, Hurlet A, Woods G, Elsas L, Embury S, Adams RJ, Stroke Prevention Trial And The Cooperative Study Of Sickle Cell Disease . Alpha Thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia. J Pediatr Hematol Oncol 2003 Aug; 25(8): 622-8.

Driscoll MC, Hurlet A, Styles L, Mckie V, Files B, Olivieri N, Pegelow C, Berman B, Drachtman R, Patel K, Brambilla D. Stroke risk in siblings with sickle cell anemia. Blood 2003 Mar; 101(6): 2401-4.

Halverson GR, Lee AH, Oyen R , Reiss RF, Hurlet A, Reid MF. Altered glycosylation leads to Tr polyagglutination. Transfusion\r\n 2004 Nov; 44(11): 1588-92.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Hurlet-Jensen did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Mount Sinai Pediatric Hematology/ Oncology

1468 Madison Avenue
New York, NY 10029

Tel: 212-241-7022
Get Directions

Office Hours:
  • Monday 9:00am - 5:00pm
  • Tuesday 9:00am - 5:00pm
  • Wednesday 9:00am - 5:00pm
  • Thursday 9:00am - 5:00pm
  • Friday 9:00am - 5:00pm
Languages:
  • French
Insurance Plans
  • Aetna
  • Beech Street
  • Devon Health Services
  • Medicaid
  • Medicare
  • Neighborhood Health Providers, LLC
  • Oxford Health Plans
  • Worker's Compensation
Payment Methods
  • Master Card
  • Visa
  • American Express
  • Personal Check
  • Cash